Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1276 studies found for:    "Macular degeneration"
Show Display Options
Rank Status Study
1 Completed Antioxidant Systems and Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention:
2 Completed Complications of Age-Related Macular Degeneration Prevention Trial
Condition: Macular Degeneration
Intervention: Procedure: Low-Intensity Laser Treatment
3 Completed Treatment of Age-Related Macular Degeneration With Anecortave Acetate
Condition: Macular Degeneration
Intervention: Drug: Anecortave Acetate Sterile Suspension (15 mg)
4 No longer available Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate
Condition: Macular Degeneration
Intervention: Drug: Anecortave Acetate
5 Unknown  A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: ALG 1001
6 Terminated 12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Drug: pazopanib eye drops
7 Terminated MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Drug: MSI-1256F (Squalamine Lactate)
8 Completed VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)
Condition: Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab;   Other: No treatment
9 Terminated
Has Results
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Regorafenib, ophthalmic oily suspension (BAY73-4506);   Procedure: Sham IVT;   Drug: Ranibizumab;   Drug: Placebo
10 Completed A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: rhuFab V2 (ranibizumab)
11 Completed
Has Results
Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Biological: aflibercept injection (VEGF Trap-Eye, BAY86-5321)
12 Completed Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Drug: AdGVPEDF.11D
13 Unknown  Copaxone in Age Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: Copaxone (Glatiramer acetate)
14 Completed Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Drug: Macugen ™ (pegaptanib sodium injection)
15 Completed Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)
Condition: Macular Degeneration
Interventions: Drug: Anecortave Acetate Sterile Suspension, 30 mg/mL;   Drug: Anecortave Acetate Sterile Suspension, 60 mg/mL;   Other: Anecortave Acetate Vehicle
16 Completed Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Drug: pegaptanib sodium
17 Completed Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Drug: rhuFab V2 (ranibizumab)
18 Completed A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: rhuFab V2 (ranibizumab)
19 Recruiting Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye
Condition: Macular Degeneration
Intervention: Drug: Eylea (Intravitreal Aflibercept, VEGF Trap-Eye, BAY86-5321)
20 Unknown  A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention: Drug: DE-120

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.